HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew R Callstrom Selected Research

Matthew R Callstrom Research Topics

Disease

60Neoplasms (Cancer)
10/2023 - 01/2006
23Neoplasm Metastasis (Metastasis)
12/2023 - 07/2002
18Pain (Aches)
11/2018 - 07/2002
7Hepatocellular Carcinoma (Hepatoma)
01/2019 - 03/2012
7Hemorrhage
01/2018 - 03/2010
5Prostatic Neoplasms (Prostate Cancer)
02/2018 - 06/2010
5Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 12/2012
3Thyroid Nodule (Nodule, Thyroid)
10/2022 - 01/2018
3Pneumothorax
01/2022 - 06/2015
3Spontaneous Fractures (Pathological Fracture)
11/2018 - 08/2010
3Pheochromocytoma
09/2011 - 03/2006
2Adenocarcinoma
01/2020 - 10/2013
2Aggressive Fibromatosis (Desmoid)
07/2016 - 02/2010
2Osteoid Osteoma
03/2012 - 10/2005
2Paraganglioma (Paragangliomas)
09/2011 - 12/2009
2Hypertensive Crisis
01/2011 - 03/2006
2Solitary Kidney
06/2010 - 08/2008
2Hematoma
06/2010 - 12/2009
1Plasmacytoma
01/2023
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2022
1Edema (Dropsy)
01/2022
1COVID-19
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Urinary Incontinence
02/2018
1False Aneurysm (Pseudoaneurysm)
08/2017
1Thrombosis (Thrombus)
08/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Kasabach-Merritt Syndrome
10/2015
1Carcinoma (Carcinomatosis)
10/2013
1Chronic Renal Insufficiency
04/2013
1Fibrosis (Cirrhosis)
03/2013
1Liver Cirrhosis (Hepatic Cirrhosis)
03/2013
1Chordoma
08/2012
1Ependymoma
08/2012
1Hematuria
01/2012
1Insulinoma
01/2012
1Hypertension (High Blood Pressure)
12/2009

Drug/Important Bio-Agent (IBA)

5salicylhydroxamic acid (SHAM)IBA
01/2019 - 03/2012
5IceIBA
10/2010 - 04/2007
4Ethanol (Ethyl Alcohol)IBA
01/2012 - 01/2006
3TOR Serine-Threonine KinasesIBA
01/2019 - 01/2016
3Analgesics (Analgesic Drugs)IBA
08/2011 - 07/2002
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2019 - 01/2016
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2019 - 01/2016
2dactolisibIBA
01/2019 - 01/2018
2PhenoxybenzamineFDA Link
01/2011 - 03/2006
1HydrogenIBA
12/2021
1NAD (NADH)IBA
12/2021
1AerosolsIBA
01/2021
1GemcitabineFDA Link
01/2020
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020
1ErbB Receptors (EGF Receptor)IBA
01/2020
1HhAntag691IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2019
1Nerve Growth Factor (NGF)IBA
12/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018
1LigandsIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
12-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA
01/2018
1Phosphotransferases (Kinase)IBA
01/2018
1ThrombinFDA Link
08/2017
1AndrogensIBA
07/2017
1Choline (Choline Chloride)IBA
06/2017
1Contrast MediaIBA
07/2016
1Protein Isoforms (Isoforms)IBA
01/2016
1Mechanistic Target of Rapamycin Complex 2IBA
01/2016
1Caspase 3 (Caspase-3)IBA
04/2014
1LuciferasesIBA
04/2014
1thiamine triphosphorate (TTP)IBA
03/2013
1Coloring Agents (Dyes)IBA
03/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2010
1CatecholaminesIBA
12/2009

Therapy/Procedure

53Cryosurgery
01/2023 - 10/2005
21Therapeutics
12/2023 - 10/2005
19Radiofrequency Ablation
10/2022 - 07/2002
12Radiotherapy
12/2023 - 07/2002
8Laser Therapy (Surgery, Laser)
01/2019 - 06/2010
6Aftercare (After-Treatment)
08/2017 - 07/2002
5Cementoplasty
01/2023 - 08/2010
4Lasers (Laser)
01/2019 - 01/2006
4Drug Therapy (Chemotherapy)
03/2012 - 07/2002
2Chest Tubes (Chest Tube)
01/2022 - 06/2015
2Prostatectomy (Retropubic Prostatectomy)
10/2013 - 07/2011
2Nephrectomy
04/2013 - 06/2010
2Palliative Care (Palliative Therapy)
06/2010 - 02/2010
2Electrodes (Electrode)
12/2007 - 07/2002
1Cesarean Section (Caesarean Section)
01/2022
1Fetal Therapies (Fetal Therapy)
01/2022
1Catheters
01/2020
1Contraindications
01/2019
1Ablation Techniques
10/2018
1Erythrocyte Transfusion
10/2015
1Stents
06/2015
1Combined Modality Therapy
08/2014
1Perioperative Period
04/2013
1Ligation
03/2012
1Length of Stay
08/2011
1Cryotherapy (Therapy, Cold)
02/2010
1Conversion to Open Surgery
12/2009